News & Events

Dr. Dhruv Khullar, an associate professor of population health sciences and of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine (ELHM) Scholar by the National Academy of Medicine.

The program, which launched in 2016, is designed to increase the organization’s engagement with outstanding interdisciplinary early- to mid-career professionals. NAM selects up to 10 people...

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain most—but not all—of their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

While injectable GLP-1s work well for weight loss, keeping the weight off after discontinuing the therapies is challenging. The results of the...

Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. The event, hosted by BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, celebrates the growing ecosystem that turns scientific discovery into scalable healthcare solutions. Speakers and panelists discussed topics ranging from AI in clinical trials to reshoring domestic drug discovery and manufacturing.

Dr. Lisa...

Weill Cornell Medicine-Qatar celebrated its largest ever graduating class, which also includes a record 22 Qatari nationals, during the institution’s commencement ceremony May 5.

The institution awarded U.S.-accredited Cornell University medical degrees to 52 new doctors, hailing from 15 countries, at the ceremony, which was attended by local dignitaries, members of the faculty, and the friends and family of the graduating students. To date, WCM-Q has graduated 693 doctors since its...

All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures. The finding points to the possibility that this same type of mechanism exists in other organisms, including humans, and may have relevance for disorders involving faulty temperature regulation.

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Launched November 2025, the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) program asks drug manufacturers to voluntarily reduce Medicaid’s prices to those paid by a group of seven peer nations including Canada, France, and the United Kingdom — a model known as Most Favored Nation pricing. States would then...

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and The University of Texas at Austin. The authors suggest that recreational cannabis laws do not fully resolve underlying systemic inequities.

The findings,...

Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine. The discovery extends the scientific understanding of the immune system, identifies a new strategy for boosting immunity against cancers and potentially offers a new tool for delivering genetic payloads to other cells.

Claire Kenney, an M.D.-Ph.D. student, received the Michael O’Dell Trainee Excellence Award from the New York Celtic Medical Society. The society provides a network for Irish-affiliated physicians in New York City.

Dr. Matthew Robbins, the Louis and Rachel Rudin Foundation Education Scholar and a professor of neurology, received the Residency Program Director Recognition Award from American Academy of Neurology. The award...

Rows of poster boards filled the Griffis Faculty Club at Weill Cornell Medicine, showcasing research ranging from cancer immunology and microbiome science to the emerging field of space biology. Standing beside them, graduate students explained months of work in a matter of minutes, fielding questions from judges, faculty and peers.

The 45th annual Vincent du Vigneaud Memorial Research Symposium held on April 16 had a record number of 153 abstracts submitted this year, including...

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies.

In the study, published April 29 in Neuron, the researchers used mouse models of the skin cancer melanoma to examine the...

Even as the national conversation around diversity, equity and inclusion is muted, Weill Cornell Medicine continues its work to make sure everyone has a seat at the table.

That was the message relayed on April 23 by Dr. Linnie Golightly, provost and senior associate dean of academic affairs at CUNY School of Medicine. Dr. Golightly was joined by Dr. Heidi Bender, inaugural associate dean for faculty engagement and inclusion, and Fanesse Acquaye, executive director of the Office of...

Researchers from Weill Cornell Medicine and Boston University School of Public Health have been awarded more than $950,000 from Arnold Ventures to create a “Medicaid Atlas” — a national, data-driven web platform that will illuminate how health care use and spending vary across Medicaid programs, plans and populations. The project will be one of the first major efforts of the...

If it wasn’t for a typo, Dr. William Schpero, a health economist and an assistant professor in population health sciences at Weill Cornell Medicine, may have taken a very different career path.

It was 2010 and he was nearing graduation from Dartmouth College, where he studied biology and government while also writing and editing for the school newspaper. Unsure of whether to pursue a career in medicine or possibly law,...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.” Normally, a B cell matures into a plasma cell that produces antibodies to fight infection, but in this case, the cells are trapped partway through the transition. They switch off key B cell features but never fully mature into functional plasma cells, instead surviving as malignant Hodgkin lymphoma cells, also...

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

The...

Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief and even strengthen the patient-caregiver bond. Weill Cornell Medicine and University of Southern California...

Advancing health equity in medicine requires a clear-eyed understanding of history, a rejection of race-based clinical assumptions and a commitment to transform research into practice, said Dr. Joseph L. Wright, senior vice president and chief health equity officer of the American Academy of Pediatrics (AAP), in his keynote address for Weill Cornell Medicine’s eighth annual Diversity Week.

Dr. Wright delivered the...

A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does. Instead, the researchers discovered that CASP5 boosts the signal to proliferate in a population of gut cells that maintains a healthy intestinal lining and replaces injured cells with new, healthy ones.

The...